{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:38:08Z","timestamp":1791934688827,"version":"4.3.4"},"reference-count":34,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["headachejournal.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Headache"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives\/Background<\/jats:title>\n                    <jats:p>This prospective, multicenter, noninterventional cohort study evaluated the impact of erenumab on the quality of life and migraine\u2010related impairment of adult patients with migraine, as well as the drug's tolerability in a real\u2010world setting over 2\u2009years. Erenumab, a fully human monoclonal antibody targeting the calcitonin gene\u2010related peptide (CGRP) receptor, was licensed in Switzerland for prophylactic treatment of adult patients with migraine in July 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult patients with chronic or episodic migraine who received erenumab treatment as per Swiss label were enrolled from 19 sites across Switzerland between February 2019 and November 2022. Inclusion criteria were defined as the following: a migraine diagnosis per International Classification of Headache Disorders, 3rd edition, patient written informed consent, and adherence to Swiss label guidelines. Exclusion criteria were concomitant use of other investigational drugs or prior treatment with erenumab or any CGRP (receptor)\u2010based therapy. Retrospective and prospective data from patients were collected over 24\u2009months using patient\u2010reported outcome questionnaires (Headache Impact Test\u20106 [HIT\u20106], modified Migraine Disability Assessment [mMIDAS], Impact of Migraine on Partners and Adolescent Children [IMPAC]), patient diaries, and medical charts to track migraine days, medication use, and health care utilization. Swiss regulations required patients to maintain migraine diaries 3 months before and during erenumab therapy to record migraine and acute medication days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 173 patients (84.9% females) were enrolled who had an average age of 44.2\u2009years. Of these, 54.3% were diagnosed with episodic migraine and 45.7% with chronic migraine. At baseline, the participants scored 65.9\u2009\u00b1\u20094.9 (mean\u2009\u00b1\u2009SD) on HIT\u20106. A total of 85.5% had grade III\u2013IV on the mMIDAS and 87% had grade III\u2013IV in IMPAC. Patients reported 16.5\u2009\u00b1\u20097.2 monthly migraine days and 11.5\u2009\u00b1\u20097.0 acute migraine\u2010specific medication days per month. After 24\u2009months, the mean HIT\u20106 score had decreased by 8.1\u2009\u00b1\u20098.6, mean mMIDAS by 16.6\u2009\u00b1\u200921.2, monthly migraine days by 8.8\u2009\u00b1\u20097.6, and mean acute migraine\u2010specific medication days by 5.2\u2009\u00b1\u20096.8 (all\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u20090.001). Reductions of IMPAC by 6.5\u2009\u00b1\u20096.6 (\n                      <jats:italic>p\u2009&lt;<\/jats:italic>\n                      \u20090.001) showed the beneficial impact of erenumab treatment on the patients' family burden attributed to migraine. Overall, 84 of 173 patients (48.6%) had at least one adverse event and 61 of 173 patients (35.3%) had at least one adverse event related to study drug. The safety profile was in line with the pivotal studies, and no serious adverse events were regarded as being related to erenumab.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, erenumab treatment significantly reduced the burden of migraine, leading to improved quality of life for patients and their families over a treatment period of 2\u2009years.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/head.14943","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T21:42:36Z","timestamp":1746049356000},"page":"1134-1147","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Swiss Quality of Life and Health Care Impact Assessment in a Real\u2010World Erenumab\u2010Treated Migraine Population: Results over 2\u2009years"],"prefix":"10.1111","volume":"65","author":[{"given":"Andreas R.","family":"Gantenbein","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurorehabilitation Zurzach Care  Bad Zurzach Switzerland"},{"name":"Department of Neurology University Hospital Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Kamm","sequence":"additional","affiliation":[{"name":"Neurocenter Luzerner Kantonsspital  Lucerne Switzerland"},{"name":"Department of Neurology Inselspital, University Hospital Bern, University of Bern  Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4668-6098","authenticated-orcid":false,"given":"Christoph J.","family":"Schankin","sequence":"additional","affiliation":[{"name":"Department of Neurology Inselspital, University Hospital Bern, University of Bern  Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zecca","sequence":"additional","affiliation":[{"name":"Neurocenter of Southern Switzerland Ente Ospedaliero Cantonale  Lugano Switzerland"},{"name":"Faculty of Biomedical Sciences University of Southern Switzerland  Lugano Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Zieglg\u00e4nsberger","sequence":"additional","affiliation":[{"name":"Department of Neurology Hospital St. Gallen  St. Gallen Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-6790","authenticated-orcid":false,"given":"Heiko","family":"Pohl","sequence":"additional","affiliation":[{"name":"Department of Neurology University Hospital Zurich  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ryvlin","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences CHUV (centre hospitalier universitaire vaudois)  Lausanne Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Agosti","sequence":"additional","affiliation":[{"name":"Kopfwehzentrum Hirslanden  Zurich Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Viceic","sequence":"additional","affiliation":[{"name":"Private Practice  Sion Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Parzini","sequence":"additional","affiliation":[{"name":"Private Practice  Carouge Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kulartz\u2010Schank","sequence":"additional","affiliation":[{"name":"Novartis Pharma Schweiz  Rotkreuz Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Arzt","sequence":"additional","affiliation":[{"name":"Novartis Pharma Schweiz  Rotkreuz Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32154-2"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-018-0113-0"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417738202"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-15-31"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03612.x"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/1129-2377-14-29"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01243-5"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130733"},{"key":"e_1_2_13_10_1","volume-title":"Therapy Recommendations","author":"Swiss Headache Society","year":"2023"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2014.20.1.22"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32504-8"},{"key":"e_1_2_13_13_1","unstructured":"Product information Aimovig. Accessed September 1 2024.www.swissmedicinfo.ch"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30083-2"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418759786"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1705848"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.14194"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10194-005-0166-1"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-021-00331-3"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01515-8"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12470-6"},{"key":"e_1_2_13_22_1","unstructured":"Schweizerische Eidgenossenschaft Spezialit\u00e4tenliste (SL) und Geburtsgebrechen\u2010Spezialit\u00e4tenliste (GGSL) Aimovig\u00ae. Accessed September 1 2024.https:\/\/www.spezialit\u00e4tenliste.ch"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102410379890"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2003.03050.x"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13028"},{"key":"e_1_2_13_26_1","volume-title":"eCRF, Datenmanagement und Statistik","author":"Raffeiner Studienmonitoring"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-023-00484-3"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2005.05.010"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102412449933"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-021-01339-y"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01514-9"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2008.01555.x"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-307149"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-017-0787-1"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420973994"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/head.14943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T08:44:54Z","timestamp":1762073094000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/head.14943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1111\/head.14943"],"URL":"https:\/\/doi.org\/10.1111\/head.14943","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"2024-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}